SCHEMBL24586396

SCHEMBL24586396

c1ccc(-c2ccc(-c3nc(-c4cc(-c5ccc(-c6ccc7ccccc7c6)cc5)c5oc6cc7ccccc7cc6c5c4)nc4ccccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ATM Q13315 1/20 0.43
MAPT P10636 5/20 0.35
ALDH1A1 P00352 3/20 0.35
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
ADORA2A P29274 3/20 0.33
NUDT1 P36639 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ADORA1 P30542 2/20 0.33
WHR1 P49842 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26416168 1.00 MEN1 (0.43) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL23597692 0.91 KMT2A (0.38) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL24255576 0.89 MEN1 (0.40) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL23597188 0.89 MEN1 (0.42) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL26416164 0.88 KDM4E (0.41) MEN1KMT2AMAPTALDH1A1ADORA2A
SCHEMBL24586855 0.88 KDM4E (0.38) MEN1KMT2AALDH1A1ADORA2ANUDT1
SCHEMBL24255570 0.88 MEN1 (0.41) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL26420727 0.88 KMT2A (0.43) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL29298621 0.86 KDM4E (0.36) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL24586564 0.86 KDM4E (0.41) MEN1KMT2AMAPTALDH1A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4261207-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT Materials Co., Ltd. (KR) 2023-10-18 EP disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230189645-A1 ORGANIC LIGHT-EMITTING DEVICE, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-06-15 US disclosed
US-20230189645-A1 ORGANIC LIGHT-EMITTING DEVICE, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-06-15 US disclosed
EP-4019505-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, METHOD FOR MANUFACTURING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT Materials Co., Ltd. (KR) 2022-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 MEN1 1044/4885KMT2A 1149/4885ATM 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.